- Vincerx Pharma press release (NASDAQ:VINC): Q1 GAAP EPS of -$0.58.
- Vincerx had roughly $5.1 million in money and money equivalents as of March 31, 2024, which doesn’t embrace the proceeds from our current financing in April, as in comparison with roughly $12.8 million as of December 31, 2023. Primarily based on its present enterprise plans and assumptions, Vincerx believes its obtainable capital, together with the current financing proceeds of roughly $17.8 million, can be enough to satisfy its working necessities by way of the top of 2024.